Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rosa damascena dry extract is a dry botanical extract manufactured from the fresh blossoms of *Rosa damascena* (Damask rose). Produced by Galen-N, the extract is obtained via water-ethanol extraction, vacuum concentration, and spray drying. It is rich in active phytochemicals, including phenolic compounds, flavonoid glycosides (such as quercetin and kaempferol), catechins, tannins, and anthocyanins. The extract is marketed as a bulk pharmaceutical, nutraceutical, and cosmetic ingredient, possessing antioxidant, anti-inflammatory, analgesic, laxative, and potential bronchodilator properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rosa damascena dry extract.